Schedule of computation of basic and diluted net income attributable to common stockholders |
|
|
|
|
|
|
|
|
|
|
Three Months
|
|
|
Ended March 31,
|
|
|
2021
|
Ordinary shares subject to possible redemption
|
|
|
|
Numerator: Earnings allocable to ordinary shares subject to possible redemption
|
|
|
|
Interest earned on marketable securities held in Trust Account
|
|
$
|
15,212
|
Unrealized loss on marketable securities held in Trust Account
|
|
|
(3,071)
|
Net Income allocable to shares subject to redemption
|
|
$
|
12,141
|
Denominator: Weighted Average Class A ordinary shares subject to possible redemption
|
|
|
|
Basic and diluted weighted average shares outstanding
|
|
|
17,950,991
|
Basic and diluted net income per share
|
|
$
|
0.00
|
|
|
|
|
Non-Redeemable Ordinary Shares
|
|
|
|
Numerator: Net income minus Net Earnings
|
|
|
|
Net Income
|
|
$
|
6,258,699
|
Less: Net income allocable to Class A ordinary shares subject to possible redemption
|
|
|
(12,141)
|
Non-Redeemable Net Income
|
|
$
|
6,246,558
|
Denominator: Weighted Average Non-Redeemable Ordinary Shares
|
|
|
|
Basic and diluted weighted average shares outstanding
|
|
|
8,955,259
|
Basic and diluted net income per share
|
|
$
|
0.70
|
|
|
|
|
|
|
|
For the
|
|
|
Period
|
|
|
from
|
|
|
August 14, 2020
|
|
|
(Inception)
|
|
|
through
|
|
|
December 31,
|
|
|
2020
|
Common stock subject to possible redemption
|
|
|
|
Numerator: Earnings allocable to Common stock subject to possible redemption
|
|
|
|
Interest earned on marketable securities held in Trust Account
|
|
$
|
18,493
|
Unrealized gain on marketable securities held in Trust Account
|
|
|
2,967
|
Net Income allocable to shares subject to redemption
|
|
$
|
21,460
|
Denominator: Weighted Average Class A common stock subject to possible redemption
|
|
|
|
Basic and diluted weighted average shares outstanding
|
|
|
18,321,541
|
Basic and diluted net income per share
|
|
$
|
0.00
|
Non-Redeemable Common Stock
|
|
|
|
Numerator: Net Loss minus Net Earnings
|
|
|
|
Net loss
|
|
$
|
(7,620,693)
|
Less: Net income allocable to Class A common stock subject to possible redemption
|
|
|
(21,460)
|
Non-Redeemable Net Loss
|
|
$
|
(7,642,153)
|
Denominator: Weighted Average Non-Redeemable Common Stock
|
|
|
|
Basic and diluted weighted average shares outstanding
|
|
|
6,764,617
|
Basic and diluted net loss per share
|
|
$
|
(1.13)
|
|
|
Schedule of computation of basic and diluted net income attributable to common stockholders |
The following table sets forth the computation of basic and diluted net income attributable to common stockholders per share (in thousands except share and per share data):
|
|
|
|
|
|
|
|
|
Three Months Ended March 31,
|
|
|
2021
|
|
2020
|
Net income attributable to common stockholders-basic
|
|
|
|
|
|
|
Net income
|
|
$
|
5,918
|
|
$
|
5,492
|
Income allocated to participating preferred stock
|
|
|
(4,000)
|
|
|
(3,838)
|
Net income attributable to common stockholders - basic
|
|
$
|
1,918
|
|
$
|
1,654
|
Net income attributable to common stockholders-diluted
|
|
|
|
|
|
|
Net income
|
|
$
|
5,918
|
|
$
|
5,492
|
Income allocated to participating preferred stock
|
|
|
(3,819)
|
|
|
(3,763)
|
Net income attributable to common stockholders - diluted
|
|
$
|
2,099
|
|
$
|
1,729
|
Weighted average shares of common stock outstanding
|
|
|
|
|
|
|
Basic weighted average shares of common stock outstanding
|
|
|
239,946
|
|
|
236,367
|
Dilutive effect of weighted average Series A warrants
|
|
|
539
|
|
|
483
|
Dilutive effect of weighted average Series B warrants
|
|
|
1,167
|
|
|
715
|
Dilutive effect of weighted average Series C-1 warrants
|
|
|
1,938
|
|
|
936
|
Dilutive effect of weighted average Series C warrants
|
|
|
397
|
|
|
—
|
Dilutive effect of weighted average stock options
|
|
|
61,020
|
|
|
25,822
|
Dilutive weighted average shares of common stock outstanding
|
|
|
305,007
|
|
|
264,323
|
Net income attributable to common stockholders per share
|
|
|
|
|
|
|
Basic
|
|
$
|
0.01
|
|
$
|
0.01
|
Diluted
|
|
$
|
0.01
|
|
$
|
0.01
|
|
|
The following table sets forth the computation of basic and diluted net income attributable to common stockholders per share (in thousands except share and per share data):
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
2020
|
|
2019
|
|
2018
|
Net income attributable to common stockholders-basic
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
12,807
|
|
$
|
13,614
|
|
$
|
2,822
|
Deemed contribution related to redemption of preferred NCI
|
|
|
—
|
|
|
—
|
|
|
5,632
|
Income allocated to participating preferred stock
|
|
|
(6,822)
|
|
|
(7,174)
|
|
|
(5,087)
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to common stockholders - basic
|
|
$
|
5,985
|
|
$
|
6,440
|
|
$
|
3,367
|
Net income attributable to common stockholders-diluted
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
12,807
|
|
$
|
13,614
|
|
$
|
2,822
|
Deemed contribution related to redemption of preferred NCI(1)
|
|
|
—
|
|
|
—
|
|
|
5,632
|
Income allocated to participating preferred stock
|
|
|
(6,387)
|
|
|
(6,945)
|
|
|
(4,977)
|
Net income attributable to common stockholders - diluted
|
|
$
|
6,420
|
|
$
|
6,669
|
|
$
|
3,477
|
Weighted average shares of common stock outstanding
|
|
|
|
|
|
|
|
|
|
Basic weighted average shares of common stock outstanding
|
|
|
236,118,856
|
|
|
234,070,277
|
|
|
229,409,649
|
Dilutive effect of weighted average Series A warrants
|
|
|
509,959
|
|
|
466,040
|
|
|
452,308
|
Dilutive effect of weighted average Series B warrants
|
|
|
930,400
|
|
|
579,050
|
|
|
469,189
|
Dilutive effect of weighted average Series C-1 warrants
|
|
|
1,413,452
|
|
|
633,290
|
|
|
389,348
|
Dilutive effect of weighted average Series C warrants
|
|
|
142,960
|
|
|
—
|
|
|
—
|
Dilutive effect of weighted average stock options
|
|
|
43,951,931
|
|
|
19,704,926
|
|
|
17,459,421
|
Dilutive weighted average shares of common stock outstanding
|
|
|
283,067,558
|
|
|
255,453,583
|
|
|
248,179,915
|
Net income attributable to common stockholders per share
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.03
|
|
$
|
0.03
|
|
$
|
0.01
|
Diluted
|
|
$
|
0.02
|
|
$
|
0.03
|
|
$
|
0.01
|
|
(1)
|
|
As further discussed in Note 13, the Company purchased Resort World’s noncontrolling interest in International on December 3, 2018. The excess carrying value of the redeemed preferred stock over the fair value of the purchase price paid was treated as a deemed contribution.
|
|
Schedule of anti-dilutive securities |
The following equity awards outstanding at the end of each period presented have been excluded from the computation of diluted net income per share of common stock for the periods presented due to their antidilutive effect:
|
|
|
|
|
|
|
Three Months Ended March 31,
|
|
|
2021
|
|
2020
|
Series C warrants
|
|
—
|
|
617
|
Series B warrants(2)
|
|
1,232
|
|
1,232
|
Stock options
|
|
885
|
|
20,053
|
A portion of the Series B warrants were excluded from the diluted net income per share calculation because they are only exercisable upon a change in control or an IPO.
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
2020
|
|
2019
|
|
2018
|
Series C warrants
|
|
—
|
|
617,192
|
|
617,192
|
Series B warrants(2)
|
|
1,231,872
|
|
1,231,872
|
|
1,231,872
|
Stock options
|
|
340,000
|
|
27,796,684
|
|
36,020,008
|
(2) A portion of the Series B warrants were excluded from the diluted net income per share calculation because they are only exercisable upon a change in control or an IPO.
|